Survey 5: Choose your language

PLEASE NOTE!

If you experience display issues with the survey, please try a different device and/or web browser.


 

LEARN MORE AND SUPPORT THE iCARE STUDY

Please invite as many of your personal and professional contacts to participate. The more people complete the survey, the more we learn about the spread and impact of COVID-19.

Learn how you can help us share this survey.

Analyses from Survey 1 (March 27 to April 15) on study demographics, perceptions of government policy, health behaviours, adherence to health measures, types of concerns, and adherence motivators (20,537 respondents, 140 countries).

View results and analyses

The iCARE Study has published a number of infographics to help share findings and analyses stemming from study data. We encourage the sharing of iCARE Study infographics on social media and other platforms, including news media and research forums.

Browse iCARE Study infographics

We encourage members of the media to contact us.

The iCARE study has received a range of local, national and international media coverage. These news stories have helped raise awareness about the importance of researching and understanding population behaviours and have helped promote participation in the survey.

Visit the iCARE media page

The iCARE study is supported by the participation of a large team of international collaborators working in different regions and countries around the world. The iCARE team shares news and more about study results, presentations, and publications as well as knowledge transfer resources.

Visit the research page

Our understanding of the determinants of adherence throughout the pandemic in countries around the world is critical for effective policy planning and communication.

The iCARE team welcomes and strongly encourages dialogue and data-sharing between researchers and policy makers. The study team makes study results, publications and policy briefs available to policy makers and community actors.

Visit the policy makers page

MORE ABOUT iCARE AND COVID-19 RESEARCH

SUMMARY STUDY DESCRIPTION

The International Assessment of COVID-19-related Attitudes, Concerns, Responses and Impacts in Relation to Public Health Policies (iCARE) study: Can we optimise strategies to flatten the COVID-19 infection curve?

The key to halting the rapid spread of COVID-19 and ‘flattening the curve’ is public adherence to drastic, rapidly evolving behaviour-based prevention policies that are being implemented around the world. However, adherence depends on: being aware of the policies (knowing what to do), believing that the policies being put in place are important; and being able to enact the policies, which may be influenced by various personal, family, job, and health-related characteristics.

Further, as we look towards de-confinement, people’s willingness to adhere to new government policies and recommendations (e.g., re: school openings, store openings) will also be critical for helping people ‘get back to normal’ and re-engaging the economy. Unfortunately, policies have varied greatly between provinces and countries, contributing to uncertainty about what the government’s priorities are (health vs. economy) and confusion about which policies to follow.

Understanding people’s concerns about COVID-19, their perceptions, beliefs, and attitudes about public health policies, and how they impact what people are (and are not) willing to do will be important for informing policy strategy and how they are communicated, to ensure the best health and economic outcomes. The iCARE Study will capture key data on people’s awareness, attitudes, and behaviours as they relate to the COVID-19 policies, as well as, the impacts that COVID-19 is having on people’s physical and mental health, financial situation, and quality of life.

Data from approximately 250,000 people around the world will be analysed to understand what government policies are (and are not) influencing behaviour and outcomes, and in whom these policies are most or least effective. This will allow us to inform governments on the efficacy of policy measures on both people’s behavior, and on key health and quality of life outcomes.

Read the complete study description


The iCARE study has been approved by the Research Ethics Committee of the CIUSSS-NIM (Centre intégré universitaire de santé et de services sociaux du Nord-de-l’Île-de-Montréal): approval # 2020-2099 / 03-25-2020.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0

SUBSCRIBE FOR UPDATES

Subscribe to receive email updates on the study and other related information.

COVID-19 GENERAL RESOURCES

RESOURCES FOR THE GENERAL POPULATION
World Health Organization (WHO) – Advice for the public
World Health Organization (WHO) – Information about COVID-19
UK National Institute for Health and Care Excellence – Information about COVID-19
US Centre for Disease Control (CDC) – Advice for the public
US National Institutes of Health (NIH) – Information about COVID-19
Cochrane Evidence – Information and resources for the public, patients, and carers
Canadian Government – Advice for the public
European Commission – Information about COVID-19
European Centre for Disease Prevention and Control (ECDC) – COVID-19 Infographics
European Centre for Disease Prevention and Control (ECDC) – Information for populations with chronic diseases
European Centre for Disease Prevention and Control (ECDC) – Information about COVID-19
European Public Health Association (EUPHA) – Information about COVID-19
COVID-19 information in Spanish (Universidad de Alcalá – Madrid)
CANADIAN RESOURCES
Public Health Agency of Canada
Canadian Psychological Association – Services for front-line healthcare workers
Canadian Public Health Association
Choosing Wisely – Canada
QUÉBEC RESOURCES
Biobanque québécoise de la COVID-19
Offre de services de l’Unité de soutien SRAP du Québec
COVID-19 data tracking (Québec)
Jeunesse j’écoute (youth help line)
Substance abuse helpline and referrals
Association québécoise de prévention du suicide (suicide prevention)
Tel-aide (support hotline)
Centre de crise de Québec (crisis support centre)
Local and regional healthcare networks – Centres intégrés de santé et de service s sociaux (CISSS) et centres intégrés universitaires de santé et de services sociaux (CIUSSS)
RESEARCH RESOURCES
Data Tracking and Simulation
WHO COVID-19 dashboard
John Hopkins University COVID-19 dashboard
The University College London (UCL) Centre for Gender and Global Health – Global Health 50/50 COVID-19 sex-disaggregated data tracker
Our World in Data (COVID-19 country data)
Health Systems, Policy and Service
WHO/EU/European observatory COVID-19 health systems response tracker
University of Oxford COVID-19 Government Response Tracker
University of Pennsylvania – Coronavirus Policy Response Simulator: Health and Economic Effects of State Reopenings
Our World in Data – Policy responses
Organisation for Economic Co-operation and Development (OECD)
Scientific updates, repositories and COVID-19 evidence
Cochrane
Cochrane COVID-19 study registry
National Center for Biotechnology Information (NCBI) LitCOVID (literature on COVID-19)
TRIP clinical search engine resources
Nature COVID-19 resources
The Lancet COVID-19 resources
British Medical Journal (BMJ) COVID-19 resources
New England Journal of Medicine (NEJM) COVID-19 resources
Journal of the American Medical Association (JAMA) Network COVID-19 resources
EBSCO Medical COVID-19 resources
Prospero (registration of studies related to COVID-19)
COVID-19 Trials Tracker
EU Clinical Trials Register

CONTACT THE iCARE TEAM

If you have any questions about the study, please contact Dr. Kim Lavoie, PhD at covid19study@mbmc-cmcm.ca.